FACTORS ASSOCIATED with SEVERE COVID-19 OUTCOMES in PATIENTS with IDIOPATHIC INFLAMMATORY MYOPATHY: RESULTS from the COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRY
Annals of the Rheumatic Diseases
; 81:165-166, 2022.
Article
in English
| EMBASE | ID: covidwho-2009023
Keywords
antirheumatic agent; corticosteroid; glucocorticoid; prednisolone; rituximab; adult; aged; comorbidity; conference abstract; controlled study; coronavirus disease 2019; demographics; effect size; female; gender; hospitalization; human; male; middle aged; myositis; outcome assessment; physician; remission; rheumatic disease; rheumatology
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Annals of the Rheumatic Diseases
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS